fbpx

DPC’s Letter to Hon. Jonathan Blum, Principal Deputy Administrator for CMS, on New Drugs in the ESRD PPS

2024-06-27T14:42:14+00:00June 11th, 2024|Categories: Advance Patient Choice, Comment Letter, Increase Quality of Care, Innovation, Protect Patient Care, Treatment Options|

June 11, 2024 The Honorable Jonathan Blum Principal Deputy Administrator Centers for Medicare & Medicaid Services 200 Independence Avenue, SW Washington, DC  20515 Re:  New drugs in the ESRD PPS Dear Principal Deputy Administrator Blum: In our comments on the 2024 ESRD payment rule, we expressed our concerns about how patients experienced the rollout of Korsuva, the drug that treats ESRD-related pruritis. We noted that the prescribing behavior of nephrologists has amounted to, in effect, a de facto embargo of the medication. Empirical research has found a prevalence of moderate to severe pruritis among dialysis patients of 33 percent, but [...]

DPC’s 2024 Advocacy Day

2024-05-23T14:34:34+00:00May 20th, 2024|Categories: Advance Patient Choice, Article, Get Involved, Improve Access to Care, Increase Quality of Care, Medigap Coverage, News, Patient Ambassadors, Private Insurance Coverage, Promote Financial Security, Protect Patient Care|

Earlier this month, DPC hosted our annual Advocacy Day in Washington, D.C. where we bring together patients, family members, and care givers to meet with their Members of Congress to elevate the patient story for dialysis patients. This year we had 65 advocates attend, representing 25 states, who had almost 80 Congressional meetings. Our patients spoke to Congressional offices asking them to support H.R. 6860 – The Restore Protections for Dialysis Patients Act and H.R. 5027 – The Chronic Kidney Disease Improvement in Research and Treatment Act. These two bills would allow dialysis patients access to private insurance and Medigap [...]

Pass Restore in ‘24

2024-05-23T14:33:35+00:00May 6th, 2024|Categories: Article, News, Private Insurance Coverage, Promote Financial Security|

Becky's daughter Dianne relied heavily on her insurance coverage that paid to treat all of her complications and extended her time with her two children. Becky's story is why Congressman Mike Kelly is fighting for the entire kidney community to ensure access to coverage for all dialysis patients. Thank you Rep. Kelly for your efforts to Pass Restore in '24. Learn more about Private Insurance Coverage and view the video.

Dialysis Patient Citizens Issues Statement on Passing of Congressman Donald Payne Jr.

2024-04-24T20:19:10+00:00April 24th, 2024|Categories: Improve Access to Care, Increase Quality of Care, News, Policy Issues, Press Release, Promote Financial Security, Protect Patient Care|

Rep. Payne Received Dialysis Treatment and Supported DPC Advocacy Efforts WASHINGTON, D.C. (April 24, 2024) - Today, Dialysis Patient Citizens (DPC) Board President Andrew Conkling issued the following statement on the passing of Rep. Donald Payne Jr. (D-NJ). Rep. Payne received dialysis treatment, advocated for better care and insurance coverage for dialysis patients, and spoke at a DPC advocacy event in Washington, DC. “We are deeply saddened to learn of the passing of Congressman Payne, who was a true friend to Dialysis Patient Citizens and a tireless advocate for dialysis patients across the country,” said DPC Board President Andrew Conkling. “Despite [...]

DPC Seeks Information on Patients’ Experience With Itching

2024-04-24T16:12:21+00:00April 24th, 2024|Categories: Advance Patient Choice, Article, Increase Quality of Care, Innovation, Medicare Advantage, Treatment Options|

A couple of years ago, a new drug was approved to treat ESRD-related pruritis. Medicare approved an additional payment for the drug Korsuva for a period of 2 years. But, because of the short expiration date, very few nephrologists prescribed the medication, so even fewer dialysis facilities dispensed the drug. As a result, Korsuva never took hold to become the standard of care for pruritis. We’d like to know (1) Have experienced pruritis? (2) If so, did your clinicians tell you about Korsuva? We would like to convey patients’ experiences as we ask for Medicare to revisit coverage: what it’s like [...]

DPC Celebrates 20th Anniversary

2024-04-24T16:16:22+00:00April 1st, 2024|Categories: About DPC, Advance Patient Choice, Article, Get Involved, Improve Access to Care, Increase Quality of Care, Patient Ambassadors, Promote Financial Security, Protect Patient Care|

Since our founding 20 years ago, Dialysis Patient Citizens (DPC) has had the privilege of working with amazing advocates to help elevate the patient voice with policy makers to improve their quality of life. At our upcoming Advocacy Day Conference, May 5 – 7, 2024, we are excited to: honor the incredible work of our patient advocates; thank key Congressional Champions; and recognize some of our kidney community allies. Advocates from across the country will also take their stories to Capitol Hill to advocate for additional patient protections. To all of our patient advocates, family members, care partners, and kidney community [...]

Indiana Passes Affordable Access to Medigap for Under-age 65 Dialysis Patients

2024-03-29T01:09:11+00:00March 15th, 2024|Categories: Article, Medicare Advantage, Medigap Coverage, Promote Financial Security, Protect Patient Care, State Advocacy|

DPC is pleased to announce that the State of Indiana has passed into law SB 215, which provides three affordable Medicare supplemental plans (also known as Medigap) to Medicare enrollees under the age of 65 – including to patients with End Stage Renal Disease (ESRD). Senator Kyle Walker (R-IN-31) championed SB 215 in the Indiana Senate. Representative David Abbott (R-IN-18), a kidney transplant recipient himself, championed a companion bill in the Indiana House of Representatives. Governor Eric J. Holcomb (R-IN) signed SB 215 into state law on March 11, 2024. We want to recognize DPC Patient Ambassador Arthur Hill, whose compelling [...]

Go to Top